{
"NDC": {
"NDCCode": "62856-405-90",
"PackageDescription": "90 TABLET, FILM COATED in 1 BOTTLE (62856-405-90) ",
"NDC11Code": "62856-0405-90",
"ProductNDC": "62856-405",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Dayvigo",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Lemborexant",
"DosageFormName": "TABLET, FILM COATED",
"RouteName": "ORAL",
"StartMarketingDate": "20200407",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA212028",
"LabelerName": "Eisai Inc.",
"SubstanceName": "LEMBOREXANT",
"StrengthNumber": "5",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cytochrome P450 2B6 Inducers [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]",
"DEASchedule": "CIV",
"Status": "Active",
"LastUpdate": "2025-03-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20200407",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}